CM – Janssen Pharma’s Xarelto-Aspirin reduces ischemic events in diseases of the peripheral arteries

0
8

Keywords:

Peripheral artery disease,Rivaroxaban,Ischemia,Aspirin,Revascularization,Johnson & Johnson,Janssen Pharmaceuticals,Peripheral artery disease, Rivaroxaban, Ischemia, Aspirin, Revascularization, Johnson & Johnson, Janssen Pharmaceuticals,,Peripheral Artery Disease,Rivaroxaban,,,,Johnson & Johnson,Bayer,Xarelto,American College of Cardiology,Eliquis,ACC 2021,peripheral artery disease,anticoagulant,bloodthinner,,,,

Donnez votre avis et abonnez-vous pour plus d’infos

[gs-fb-comments]

Vidéo du jour: